Phentermine and fenfluramine preclinical studies in animal models of cocaine addiction

Annals of the New York Academy of Sciences

Volumn 844, Issue , 1998, Pages 59-74

  Rothman, Richard B ^a,b   Elmer, Gregory I ^b   Shippenberg, Toni S ^a,c   Rea, William ^a   Baumann, Michael H ^a  

^a Behavioral Neuroscience Section   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; DOPAMINE; FENFLURAMINE; MORPHINE; PHENTERMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG DEPENDENCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIMBIC SYSTEM; LOCOMOTION; MALE; MICRODIALYSIS; MOTIVATION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PLACE PREFERENCE; RAT; RELAPSE; REWARD; SEROTONIN RELEASE; STEREOTYPY; WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0031818199     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08222.x     Document Type: Article

References (40)

1. BAUMANN, M. H., K. M. BECKETTS & R. B. ROTHMAN. 1995. Evidence for alterations in presynaptic serotonergic function during withdrawal from chronic cocaine in rats. Eur. J. Pharmacol. 282: 87-93.
2. KUHAR, M. J. & N. S. PILOTTE. 1996. Neurochemical changes in cocaine withdrawal. Trends Pharmacol. Sci. 17(7): 260-264.
3. WEISS, F., Y. L. HURD, U. UNGERSTEDT, A. MARKOU, P. M. PLOTSKY & G. F. KOOB. 1992. Neurochemical correlates of cocaine and ethanol self-administration. Ann. N. Y. Acad. Sci. 654: 220-241.
4. PARSONS, L. H., G. F. KOOB & F. WEISS. 1995. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274: 1182-1191.
5. CUNNINGHAM, K. A., J. M. PARIS & N. E. GOEDERS. 1992. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11: 112-123.
6. GAWIN, F. H. & H. D. KLEBER. 1986. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 43: 107-113.
7. DACKIS, C. A. & M. S. GOLD. 1985. New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9: 469-477.
8. ROY, A., J. DE JONG & M. LINNOILA. 1989. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch. Gen. Psychiatry 46: 609-612.
9. ROY, A. & M. LINNOILA. 1988. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr. Scand. 78: 529-535.
10. ROTHMAN, R. B., T. M. GENDRON & P. HITZIG. 1994. Combined use of fenfluramine and phentermine in the treatment of cocaine addiction: A pilot case series. J. Subst. Abuse Treat. 11: 273-275.
11. HITZIG, P. 1993. Combined dopamine and serotonin agonists: A synergistic approach to alcoholism and other addictive behaviors. Maryland Med. J. February: 153-157.
12. HITZIG, P. 1994. Combined serotonin and dopamine indirect agonists correct alcohol craving and alcohol-associated neurosis. J. Subst. Abuse Treat. 11: 489-490.
13. ROTHMAN, R. B. 1995. Treatment of alcohol and cocaine addiction by the combination of pemoline and fenfluramine: A preliminary case series. J. Subst. Abuse Treat. 12: 449-453.
14. BAUMANN, M. H., G. U. CHAR, B. R. DE COSTA, K. C. RICE & R. B. ROTHMAN. 1994. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271: 1216-1222.
15. PAXINOS, G. 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press. New York.
16. SHIPPENBERG, T. S., C. HEIDBREDER & A. LEFEVOUR. 1996. Sensitization to the conditioned rewarding effects of morphine: Pharmacology and temporal aspects. Eur. J. Pharmacol. 299: 33-39.
17. KUHAR, M. J., M. C. RITZ & J. W. BOJA. 1991. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14: 299-302.
18. ROTHMAN, R. B., M. AYESTAS & M. H. BAUMANN. 1996. Phentermine pretreatment antagonizes the cocaine-induced rise in mesolimbic dopamine. Neuroreport 8: 7-9.
19. ROBINSON, T. E. & K. C. BERRIDGE. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291.
20. BRAUER, L. H., C. E. JOHANSON, C. R. SCHUSTER, R. B. ROTHMAN & H. DE WIT. 1996. Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers. Neuropsychopharmacolocy 14: 233-241.
21. GLOWA, J. R., F. H. E. WOJNICKI, D. MATECKA, K. C. RICE & R. B. ROTHMAN. 1995. Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II: comparisons with other drugs and repeated administrations. Exp. Clin. Psychopharmacol., 3: 232-239.
22. GLOWA, J. R., K. C. RICE, D. MATECKA & R. B. ROTHMAN. 1997. Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys. Neuroreport 8: 1347-1351.
23. WISE, R. A. 1981. Brain dopamine and reward. In Theory in Psychopharmacology. S. J. Cooper, Ed. 103-122. Academic Press. London & New York.
24. HOEBEL, B. G., L. HERNANDEZ, D. H. SCHWARTZ, G. P. MARK & G. A. HUNTER. 1989. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann. N. Y. Acad. Sci. 575: 171-191; discussion.
25. DI CHIARA, G. & A. IMPERATO. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278.
26. GORELICK, D. A. 1997. Pharmacologic therapies for cocaine and other stimulant addiction. In Principles of Addiction Medicine. A. W. Graham & T. K. Schultz, Eds. American Society of Addiction Medicine. Chevy Chase, MD. In press.
27. SHOAIB, M., M. H. BAUMANN, R. B. ROTHMAN, S. R. GOLDBERG & C. W. SCHINDLER. 1997. Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology (Berlin) 131: 296-306.
28. KELLY, P. H., P. W. SEVIOUR & S. D. IVERSEN. 1975. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res., 94: 507-522.
29. PIGOTT, T. A., F. L'HEUREUX, B. DUBBERT, S. BERNSTEIN & D. L. MURPHY. 1994. Obsessive compulsive disorder: Comorbid conditions. (Review, 145 refs.) J. Clin. Psychiatry 55(Suppl.): 15-27; discussion.
30. CALABRESE, G., C. COLOMBO, A. BONFANTI, G. SCOTTI & S. SCARONE. 1993. Caudate nucleus abnormalities in obsessive-compulsive disorder: Measurements of MRI signal intensity. Psychiatry Res. 50: 89-92.
31. SCARONE, S., C. COLOMBO, S. LIVIAN, M. ABBRUZZESE, P. RONCHI, M. LOCATELLI, G. SCOTTI & E. SMERALDI. 1992. Increased right caudate nucleus size in obsessive-compulsive disorder: Detection with magnetic resonance imaging. Psychiatry Res. 45: 115-121.
32. BAXTER, L. R., JR., J. M. SCHWARTZ, K. S. BERGMAN, M. P. SZUBA, B. H. GUZE, J. C. MAZZIOTTA, A. ALAZRAKI, C. E. SELIN, H. K. FERNG, P. MUNFORD et al. 1992. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiatry 49: 681-689.
33. BENKELFAT, C., T. E. NORDAHL, W. E. SEMPLE, A. C. KING, D. L. MURPHY & R. M. COHEN. 1990. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch. Gen. Psychiatry 47: 840-848.
34. ROSSE, R. B., M. FAY-MCCARTHY, J. P. COLLINS, JR., T. N. ALIM & S. I. DEUTSCH. 1994. The relationship between cocaine-induced paranoia and compulsive foraging: A preliminary report. Addiction 89: 1097-1104.
35. 3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J. Pharmacol. Exp. Ther. 264: 1440-1449.
36. 2 receptor agonists quinpirole and bromocriptine produce conditioned place preferences. Prog. Neuropsychopharmacol. Biol. Psychiatry 12: 315-322.
37. MIROVSKY, Y., Y.-L. YU, G. C. WAGNER, A. SEKOWSKI, M. GOLDBERG & H. FISHER. 1995. Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists. Alcohol Clin. Exp. Res. 19: 160-163.
38. YU, Y. L., H. FISHER, A. SEKOWSKI & G. C. WAGNER. 1997. Amphetamine and fenfluramine suppress ethanol intake in ethanol-dependent rats. Alcohol 14: 45-48.
39. CONNOLLY, H. M., J. L. CRARY, M. D. MCGOON, D. D. HENSRUD, B. S. EDWARDS & H. V. SCHAFF. 1997. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337: 581-588.
40. MCCANN, U. D., L. S. SEIDEN, L. J. RUBIN & G. A. RICAURTE. 1997. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the literature. JAMA 278: 666-672.